No Result
View All Result
  • Login
  • Register
Business & Technology
SUBSCRIBE
  • .
  • Thought Leadership
  • Conversations
  • International Voices
  • News
  • Wealth
  • Digital Transformation
  • Lifestyle
  • Videos
  • Podcasts
  • .
  • Thought Leadership
  • Conversations
  • International Voices
  • News
  • Wealth
  • Digital Transformation
  • Lifestyle
  • Videos
  • Podcasts
No Result
View All Result
Biztech Asia
Home News

UK the 1st to approve Pfizer-BioNTech Covid vaccine

by editorial
03/12/20
in News
2 min read
0
Vaccines breakthroughs call for cautious optimism

The UK became the first country to approve the US-German vaccine and will be rolled out next week, with elderly people in care homes and medical workers first in line, marking another step in the global battle against the pandemic.

This makes Britain one of the first countries to begin vaccinating its population. The UK government has accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s Covid-19 vaccine for use.

But, Emergency use approval in the United States is under review by the Food and Drug Administration.

According to Pfizer’s Chairman and CEO, Dr. Albert Bourla, the authorisation was a “historic moment” and a goal they have been working toward since they first declared that science will win. With thousands of people becoming infected, every day matters in the collective race to end this devastating pandemic.

In July, Pfizer and BioNTech announced an agreement with the UK to supply 30 million doses of its mRNA-based vaccine, formally known as BNT162b2, once authorised for emergency use but has been increased to 40 million doses in early October. As a two-dose vaccine, the UK will have enough doses to vaccinate around a third of its 66 million population.

In a statement, BioNTech said that the delivery of the 40 million doses will occur throughout 2020 and 2021, with complete delivery fulfilment expected next year.

A spokesman for the UK’s Department of Health and Social Care said the Joint Committee on Vaccinations and Immunisations will shortly publish its final advice for the priority groups to receive the vaccine, including care home residents, health and care staff, the elderly and the clinically extremely vulnerable.

Pfizer and BioNTech said they had applied to the European Medicines Agency for the conditional marketing authorization of the vaccine.  If the authorisation is granted, it could enable use of the vaccine in Europe this month, BioNTech said, although the EMA later said that it would complete its review of the vaccine by Dec. 29.

According to data from Johns Hopkins University, time is of the essence when it comes to rolling out a vaccine, particularly for the UK. It has the third highest number of confirmed cases in Europe, after France and Spain, with over 1.6 million infections.

One EU lawmaker raised questions about the UK.’s decision to authorise Pfizer’s vaccine. He considers this decision to be problematic and recommend that EU Member States do not repeat the process in the same way.  A few weeks of thorough examination by the European Medicines Agency is better than a hasty emergency marketing authorisation of a vaccine.

Previous Post

Personal Finance 101- Getting your finances in Order

Next Post

Singapore’s DBS bank outlines trades ideas and strategies for 2021 in rates, currencies and credit

editorial

editorial

Related Posts

Bitcoin and US tech stocks, the biggest market bubbles now
News

Bitcoin and US tech stocks, the biggest market bubbles now

Watsons and Grab in regional O+O partnership
News

Watsons and Grab in regional O+O partnership

MDEC appoints new chief financial officer
News

MDEC appoints new chief financial officer

M&A valuations boom in the second half of 2020 despite impacts of the pandemic
News

M&A valuations boom in the second half of 2020 despite impacts of the pandemic

Greater China equities – a resilient way forward
News

Growing foreign interest pours into China

News

Biden’s inauguration in focus; markets off to a sluggish start

Next Post
Singapore’s DBS bank outlines trades ideas and strategies for 2021 in rates, currencies and credit

Singapore's DBS bank outlines trades ideas and strategies for 2021 in rates, currencies and credit

China’s Dual Circulation Pivot

Take some profits, but also profit from unusual volatility before year end

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

I agree to the Terms & Conditions and Privacy Policy.

Recommended Stories

MOSAIC a poetic metaphor – a reflection of hope and harmony between human and nature

MOSAIC a poetic metaphor – a reflection of hope and harmony between human and nature

How Covid-19  has rewritten the rules of recruitment?

How Covid-19 has rewritten the rules of recruitment?

The future of work: A shift from HQ to Business Center

The future of work: A shift from HQ to Business Center

Popular Stories

  • Economic recovery: an elusive thought?

    Economic recovery: an elusive thought?

    0 shares
    Share 0 Tweet 0
  • Cannibalising your business can be profitable

    0 shares
    Share 0 Tweet 0
  • Sexual fulfillment builds confidence and well-being

    0 shares
    Share 0 Tweet 0
  • Tech Stocks – Ant gets stomped on but REITS offer stability amid volatility

    0 shares
    Share 0 Tweet 0
  • Singapore REITS and China tech stocks – Which should you buy?

    0 shares
    Share 0 Tweet 0

About Us

A Business and Technology digital publication that engages business leaders in business and technology conversations to help everyone pivot, adapt, and thrive in these turbulent times.

LEARN MORE »

Contact Us

Phone: 016-2011 050

Email: editor@biztech.asia

Address:
Level 18, Boutique Office 1 (B01-C)
Menara 2, No. 3, Jalan Bangsar,
KL Eco City, 59200, Kuala Lumpur.

Email Newsletter

Loading

© 2020 Business & Technology - made possible by Milestones Digital.

No Result
View All Result
  • Home
  • Thought Leadership
  • Conversations
  • International Voices
  • News
  • Wealth
  • Digital Transformation
  • Lifestyle
  • Videos
  • Podcasts
  • Login
  • Sign Up

© 2020 Business & Technology - made possible by Milestones Digital.

Welcome Back!

Sign In with Facebook
Sign In with Google
OR

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Sign Up with Facebook
Sign Up with Google
OR

Fill the forms bellow to register

*By registering into our website, you agree to the Terms & Conditions and Privacy Policy.
All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.
Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

will use the information you provide on this form to be in touch with you and to provide updates and marketing.